Literature DB >> 12484705

Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative Staphylococcus ocular surface infection efficacy of chloramphenicol eye drops.

Masahiko Fukuda1, Hideyuki Ohashi, Chota Matsumoto, Soichiro Mishima, Yoshikazu Shimomura.   

Abstract

PURPOSE: Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant coagulase-negative Staphylococcus (MR-CNS) are two major multidrug-resistant pathogens. In this paper we report the prevalence of MRSA and MR-CNS in ocular surface infections.
METHODS: We investigated the proportion of MRSA and MR-CNS in bacterial isolates from conjunctiva of elderly patients with and without bacterial conjunctivitis. The relationship between conjunctival MRSA carriers and general background conditions was studied. We evaluated the efficacy of chloramphenicol eye drops in the treatment of MRSA conjunctivitis. We also investigated the presence of MRSA and MR-CNS in lid skin and conjunctiva of patients with atopic dermatitis.
RESULTS: In conjunctival bacterial flora of elderly patients the proportion of MRSA in S. aureus was 57%, and the proportion of MR-CNS in coagulase-negative Staphylococcus was 25%. Conjunctival MRSA carriers were more likely to have anemia, malignant tumor, liver dysfunction, and dementia, and to be postoperation and chronically bedridden. The efficacy rate of chloramphenicol eye drops in the treatment of MRSA conjunctivitis was 81%. In conjunctival sacs of patients with atopic dermatitis, S. aureus was the most frequent species (48%), and the proportion of MRSA was 18%.
CONCLUSION: Methicillin-resistant S. aureus and MR-CNS are widespread in elderly hospitalized patients and in patients with atopic dermatitis. Chloramphenicol eye drops were useful for the treatment of MRSA ocular surface infections.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12484705     DOI: 10.1097/01.ico.0000263125.99262.42

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  23 in total

1.  [Multiresistant bacteria in ophthalmology].

Authors:  T Ness
Journal:  Ophthalmologe       Date:  2010-04       Impact factor: 1.059

2.  Dacryocystitis: Systematic Approach to Diagnosis and Therapy.

Authors:  Sergio Pinar-Sueiro; Mercedes Sota; Telmo-Xabier Lerchundi; Ane Gibelalde; Bárbara Berasategui; Begoña Vilar; Jose Luis Hernandez
Journal:  Curr Infect Dis Rep       Date:  2012-01-29       Impact factor: 3.725

3.  Neonatal methicillin resistant Staphylococcus aureus conjunctivitis.

Authors:  D N Sahu; S Thomson; A Salam; G Morton; P Hodgkins
Journal:  Br J Ophthalmol       Date:  2006-06       Impact factor: 4.638

4.  Acute systemic immune activation following conjunctival exposure to staphylococcal enterotoxin B.

Authors:  Govindarajan Rajagopalan; Michele K Smart; Robin Patel; Chella S David
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

5.  Methicillin-resistant Staphylococcus aureus infections of the eyes.

Authors:  Itzhak Brook
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

6.  Profiling transcriptomic changes and signaling pathways in atopic dermatitis by integrative analyses on multiple databases.

Authors:  Yubin Xu; Saizhen Chen; Jinguang Chen
Journal:  Mol Genet Genomics       Date:  2021-01-13       Impact factor: 3.291

7.  The role of topical moxifloxacin, a new antibacterial in Europe, in the treatment of bacterial conjunctivitis.

Authors:  Jose Benitez-Del-Castillo; Yves Verboven; David Stroman; Laurent Kodjikian
Journal:  Clin Drug Investig       Date:  2011       Impact factor: 2.859

8.  Methicillin-resistant Staphylococcus aureus infections of the eye and orbit (an American Ophthalmological Society thesis).

Authors:  Preston Howard Blomquist
Journal:  Trans Am Ophthalmol Soc       Date:  2006

9.  Two cases of methicillin-resistant Staphylococcus aureus keratitis after Epi-LASIK.

Authors:  Norimasa Nomi; Naoyuki Morishige; Naoyuki Yamada; Tai-Ichiro Chikama; Teruo Nishida
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

10.  Does single application of topical chloramphenicol to high risk sutured wounds reduce incidence of wound infection after minor surgery? Prospective randomised placebo controlled double blind trial.

Authors:  Clare F Heal; Petra G Buettner; Robert Cruickshank; David Graham; Sheldon Browning; Jayne Pendergast; Herwig Drobetz; Robert Gluer; Carl Lisec
Journal:  BMJ       Date:  2009-01-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.